Pharmafarm staff are preparing corrective and preventive measures to submit to the NAMMD, Richter said. The suspension of the companyʼs operating license is expected to be lifted once the authority approves those measures, it added.
Zsuzsa Beke, Richterʼs head of communications and public affairs, told state news agency MTI that the suspension is disproportionately severe. Richter expects the suspension, which will last for at least two months, will result in EUR 20 million lost revenue monthly and a significant loss of market confidence, she added, noting that there could be shortages of some products on the Romanian market and the jobs of Pharmafarmʼs 500 staff could be threatened.
Richter acquired Pharmafarm in 2007.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
